Accueil › Cancer métastatique › Ohio › Cleveland
Essais cliniques pour Cancer métastatique à Cleveland, OH
30 études pour Cancer métastatique recherchent des participants dans et autour de Cleveland (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Cleveland
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Recrutement en coursPhase 2
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · à 10 mi
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · à 22 mi
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- University Hospitals Cleveland Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Recrutement en coursPhase 1
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Study of ASP3082 in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1
- Case Western, Cleveland
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Recrutement en coursPhase 2/3
- University Hospitals Cleveland Medical Center, Cleveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Recrutement en coursPhase 3
- Research Site, Cleveland
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Recrutement en coursPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- et 1 autres
SLV-154 Treatment of Advanced Cancers
Recrutement en coursPhase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Recrutement en coursPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · à 12 mi
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Recrutement en coursPhase 1/2
- University Hospitals Cleveland Medical Center, Cleveland
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recrutement en coursPhase 3
- Cleveland Clinic, Cleveland
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Recrutement en coursPhase 1
- Cleveland Clinic, Cleveland
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Recrutement en coursPhase 3
- Research Site, Cleveland
- Research Site, Cleveland
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Recrutement en coursPhase 1
- University Hospitals of Cleveland, Cleveland
REMASTer: REcurrent Brain Metastases After SRS Trial
Recrutement en cours
- Cleveland Clinic, Cleveland
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Research Site, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Recrutement en coursPhase 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Recrutement en coursPhase 2/3
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Cleveland Clinic, Cleveland
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Recrutement en coursPhase 3
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Mayfield Heights · à 12 mi
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Recrutement en coursPhase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Recrutement en coursPhase 1/2
- Cleveland Clinic, Cleveland
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer
Recrutement en coursPhase 1
- Case Western Reserve University, Cleveland
Essais pour Cancer métastatique dans d'autres villes
- Houston, TX104 études
- New York City, NY93 études
- Nashville, TN70 études
- Boston, MA63 études
- Los Angeles, CA57 études
- St. Louis, MO54 études
- Arlington, VA53 études
- Philadelphia, PA46 études
- Chicago, IL45 études
- San Antonio, TX44 études
- Washington, DC43 études
- Dallas, TX42 études
Autres études à Cleveland
- Cancer du poumon non à petites cellules43 études
- Cancer (tous types)36 études
- Cancer du sein35 études
- Cancer de la prostate34 études
- Insuffisance cardiaque33 études
- Cancer de l'ovaire30 études
- Cancer du poumon26 études
- Cancer colorectal24 études
- Maladie cardiovasculaire22 études
- Cancer de l'endomètre20 études
- Leucémie aiguë myéloïde20 études
- Maladie de Crohn19 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.